NCT06639139 The Effectiveness of Cognitive-Functional Remote Group Intervention (Cog-Fun RG) for Adults with Attention Deficit Hyperactivity Disorder (ADHD)
| NCT ID | NCT06639139 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hebrew University of Jerusalem |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-11 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-11 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine the effectiveness of Cognitive-Functional Remote Group intervention (Cog-Fun RG). The main questions of this study are 1. will participants demonstrate improvements in their executive functioning and quality of life after receiving the intervention, compared to waitlist controls. In addition, the investigators will examine if the waitlist group will demonstrate similar gains in these outcomes after receiving the same intervention. the investigators will compare between the intervention group to the waiting list group to examine the effect of the intervention. The participants will be allocated into two groups: an intervention group and a waiting list group. The intervention group will receive the the Cog-Fun RG intervention, which includes 21 weekly group sessions, each lasting 90 minutes. the participants will be required to complete questionnaires at several time points: pre-post the intervention, as well as three months, six months, and one year after the intervention. The waiting list controls will be required to complete questionnaires at several time points: pre-post waiting period, and then after the intervention, as well as three months, six months, and one year after the intervention.
Eligibility Criteria
Inclusion Criteria: \* Self Reported ADHD diagnoses Exclusion Criteria: \* Self Reported other major health condition that impedes daily functioning
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06639139 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06639139 currently recruiting?
Yes, NCT06639139 is actively recruiting participants. Contact the research team at adina.maeir@mail.hui.ac.il for enrollment information.
Where is the NCT06639139 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT06639139 clinical trial?
NCT06639139 is sponsored by Hebrew University of Jerusalem. The trial plans to enroll 40 participants.